|
|
 |
|
Viewing report
|
|
|
|
Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe
Frost & Sullivan, April 2011, Pages: 124
This research examines the Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe in terms of the challenges faced by market participants, drivers and restraints in the industry. The main chapters of the research service include an executive summary, overview of the market and in-depth analysis of revenues, pricing, industry challenges,strategic recommendations, market drivers and restraints pertaining to this market. The analysis also covers the competitive landscape, market trends by hospital type, solution type and market forecasts in different regions of Europe. This research also provides an understanding about the various market trends
Research Overview
This Frost & Sullivan research service titled Advanced (3D/4D) Visualisation and Clinical Applications Markets in Europe provides an in-depth analysis of challenges, drivers and restraints faced by market participants. It also provides revenue forecasts, competitive structure and geographic analysis.
Market Overview
Significant Operational Gains and Enhanced Patient Safety Promote Appeal of Advanced (3D/4D) Visualisation and Clinical Applications
Hospital end users are becoming increasingly receptive to the expanded range of clinically specific 3D/4D applications that imaging companies offer over and above generic 3D imaging capabilities. These include publicity-attracting procedures such as virtual colonoscopy and CT and MR angiography, which coupled with a dynamic patient archiving and communications systems (PACS) market, and boosted by healthcare authority investment in the digitisation of patient data represents great potential for the future growth of 3D/4D imaging companies. “The primary advantage of advanced (3D/4D) visualisation and clinical applications is that the digital image can be manipulated,” notes the analyst of this research. “For example, an area can be magnified or the contrast and density can be changed to enhance the quality of the image.”
Digital images are more tolerant of over- and under-exposure, which minimises the need for repeat studies. Computer-aided detection can also be applied to aid decision making. Image manipulation capabilities will be a major driver for using advanced (3D/4D) visualisation and clinical applications. “In addition, the actual patient safety and operational gains made possible by advanced (3D/4D) visualisation and clinical applications are significant,” adds the analyst. “The drive to improve precision and accuracy through standardised methods and advanced image analysis ultimately leads to improved patient safety, reduced turnaround times and reduced cost per examination.”
Supportive Policies and Financial Incentives to Accelerate and Widen Adoption
Healthcare organisations across Europe have their budgets pre-planned for specific activities, and advanced visualisation vendors recognise the lack of funding for large-scale projects. This difficulty of securing funding, combined with the scarcity of internal resources within hospitals, can cause long delays in sales cycles and can even result in projects being postponed. “Despite the evolution of advanced visualisation solutions towards being multi-modality, enterprise-wide solutions, there remains a strong correlation today between the sale of these solutions and the sale of new CT imaging equipment, which more often than not is sold with an advanced imaging and 3D image reconstruction solution,” explains the analyst. “This dependence on CT is expected to have a negative impact on the advanced visualisation (3D/4D) market as sales of new high-end scanners have shown signs of slowing down over the next few years.”
Many organisations do not recognise a clear business case for financial and organisational investments in advanced (3D/4D) visualisation and clinical applications for medical imaging. 3D/4D vendors need to collaborate with end users to address those issues and demonstrate a clear ROI. As in the case for other healthcare information technologies, the costs associated with advanced (3D/4D) visualisation and clinical applications implementation are typically borne primarily by healthcare organisations, while many of the benefits accrue to patients, payers and society as a whole in terms of improved healthcare. Supportive policies and new financial incentives would help to redress these deficiencies and accelerate the more widespread adoption of 3D/4D tools.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following geographic areas in this research:
- The United Kingdom
- Italy
- France
- Spain
- Germany
- Scandinavia (Denmark, Sweden, Norway and Finland)
- Benelux (Belgium, the Netherlands and Luxembourg)
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
